Pfizer Inc (PFE)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 213,396,000 | 226,501,000 | 197,206,000 | 181,477,000 | 154,229,000 |
| Total stockholders’ equity | US$ in thousands | 88,203,000 | 89,014,000 | 95,661,000 | 77,201,000 | 63,238,000 |
| Financial leverage ratio | 2.42 | 2.54 | 2.06 | 2.35 | 2.44 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $213,396,000K ÷ $88,203,000K
= 2.42
The financial leverage ratio of Pfizer Inc has experienced fluctuations over the past five years. As of December 31, 2020, the ratio stood at 2.44, indicating that the company had $2.44 in debt for every $1 of equity. This ratio decreased to 2.35 by the end of 2021, suggesting a slight improvement in the company's leverage position.
Subsequently, by December 31, 2022, Pfizer's financial leverage ratio decreased further to 2.06, signaling a reduction in the company's reliance on debt financing. However, the ratio increased to 2.54 by the end of 2023, indicating a higher level of debt relative to equity compared to the previous year.
As of December 31, 2024, Pfizer's financial leverage ratio decreased slightly to 2.42, showing a moderate leverage position. Overall, the trend in Pfizer's financial leverage ratio demonstrates some variability over the years, with the company's leverage position improving in some years and deteriorating in others.
Peer comparison
Dec 31, 2024